3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumor
1
Interventions
pembrolizumab
305
Paclitaxel
205
Carboplatin
201
Gemcitabine
173
Cisplatin
140
Docetaxel
138
Cyclophosphamide
137
Nivolumab
129
Bevacizumab
118
Injections
112
fludarabine
97
atezolizumab
91
Pemetrexed
91
Dexamethasone
90
Cetuximab
90
Fluorouracil
84
Irinotecan
77
Rituximab
72
Capecitabine
72
venetoclax
71
Azacitidine
70
130-nm albumin-bound paclitaxel
67
Leucovorin
65
Fulvestrant
58
Oxaliplatin
57
durvalumab
56
Trastuzumab
56
Midazolam
55
Lenalidomide
55
Ipilimumab
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
INDUSTRY
×
MK-4166
×
Clear all
NCT02132754
2021-01-28
MK-4166-001
Merck Sharp & Dohme LLC
Phase 1
Completed
116 enrolled
61 charts